Unicycive Therapeutics UNCY
NASDAQ UNCY
$3.87 +0.07 (+1.84%)
At close: Oct 21, 2026 · 4:00 PM EDT

Unicycive Therapeutics (UNCY) Operating Margin (2022 - 2023)

Updated

Unicycive Therapeutics' Operating Margin came in at -3077.63% for FY2023, down 1179.42 percentage points from -1898.21% in FY2022.

Analysis

Unicycive Therapeutics (UNCY) Operating Margin (2022 - 2023) Analysis & Trends

  • Per Business Quant, earlier years put Operating Margin at -1898.21% in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 28.21%
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 37.86%
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -3.52%
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 32.97%
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 20.57%
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 34.95%
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -133.21%
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 28.37%
10 Unicycive Therapeutics 104.17 Mn -95.81 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 -622.52%
Sep 30, 2022 -584.02%
API Access

Unicycive Therapeutics Operating Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-margin&ticker=UNCY&period=max&api_key=YOUR_API_KEY